Notes on the 2018 Longevity Forum in London

The Longevity Forum, hosted by investor Jim Mellon and company yesterday in London, was a reminder that we still have a way to go when it comes to guiding the conversation on longevity and rejuvenation in a useful direction. On the one hand, most people give medicine and aging little serious thought until it is too late, and if we want large-scale...
Fight Aging!
Lifespan.io Hero

The Longevity Forum, hosted by investor Jim Mellon and company yesterday in London, was a reminder that we still have a way to go when it comes to guiding the conversation on longevity and rejuvenation in a useful direction. On the one hand, most people give medicine and aging little serious thought until it is too late, and if we want large-scale funding for the goal of human rejuvenation through realization of the SENS research agenda, then the public at large really has to be on board in the same way that they are reflexively in favor of doing something about cancer and Alzheimer’s disease. On the other hand, the first reaction of many people when presented with the concept of enhanced human longevity is to fixate on line items that really do not matter in the grand scheme of things: whether retirement will still exist; will life insurance companies have to change their ways; will some particular demographic gain slightly more than another as a result to progress in medicine. None of these points matter anywhere near as much as does the act of building the therapies that will save lives and improve lives.

I

Source: aggregator.leafscience.org